Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: Wright Reports
Provider: New Constructs, LLC
Provider: ValuEngine, Inc.

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

BioScrip Inc gives FY 2014 guidance above analysts' estimates

Thursday, 8 May 2014 10:55pm EDT 

BioScrip Inc:Sees FY 2014 revenue to be in a range of $940.0 million to $980.0 million.Sees FY 2014 Adjusted EBITDA will be in a range of $55.0 million to $60.0 million.FY 2014 revenue estimates of $713 mln -Thomson Reuters I/B/E/S.FY 2014 adjusted EBITDA estimates of $54 - Thomson Reuters I/B/E/S. 

Company Quote

0.07 +0.94%
23 Jul 2014